Giuseppe Roscilli

Takeda (Italy) — Italy

Medicine · Health Sciences

29h-index2.8kcitations73works14.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(16), Immunotherapy and Immune Responses(13), Virus-based gene therapy research(10), Cancer Cells and Metastasis(8), Glycosylation and Glycoproteins Research(6)

Publications73 total

Novel Humanized Anti-HER3 Antibodies: Structural Characterization and Therapeutic Activity
Antibodies·2025Open Access
From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy
Journal of Translational Medicine·2025· 40 citedOpen Access
Design, Synthesis and Preliminary In‐Vitro Activity of 6‐Hydroxyalkyl β‐Carboline Derivatives for the Development of Drug Conjugates Targeting MDM2
European Journal of Organic Chemistry·2024· 1 citedOpen Access
On-chip recapitulation of the tumor microenvironment: A decade of progress
Biomaterials·2024· 29 citedOpen Access
Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
Antibodies·2024· 3 citedOpen Access
Kinetic Detection of Apoptosis Events Via Caspase 3/7 Activation in a Tumor-Immune Microenvironment on a Chip
Methods in molecular biology·2023· 1 cited
Isolation and characterization of neutralizing monoclonal antibodies from a large panel of murine antibodies against RBD of the SARS-CoV-2 Spike protein
2023Open Access
Relevance of Spike/Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
Signal Transduction and Targeted Therapy·2023· 4 citedOpen Access
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
Vaccines·2023· 4 citedOpen Access
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
Molecular Therapy — Methods & Clinical Development·2023· 8 citedOpen Access
Immunogenicity of COVID-eVax Is Moderately Impacted by Temperature and Molecular Isoforms
2022Open Access
A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
Molecular Therapy·2022· 24 citedOpen Access
Relevance of the viral Spike protein/cellular Estrogen Receptor-α interaction for endothelial-based coagulopathy induced by SARS-CoV-2
2022· 1 citedOpen Access
Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections
Cell Host & Microbe·2022· 120 citedOpen Access
Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections
Frontiers in Microbiology·2021· 1 citedOpen Access
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression
Biomolecules·2021· 27 citedOpen Access
A new humanized antibody is effective against pathogenic fungi in vitro
Scientific Reports·2021· 26 citedOpen Access
Highly Specific Memory B Cells Generation after the 2nd Dose of BNT162b2 Vaccine Compensate for the Decline of Serum Antibodies and Absence of Mucosal IgA
Cells·2021· 77 citedOpen Access
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
Molecular Therapy·2021· 67 citedOpen Access
The nuts and bolts of SARS-CoV-2 Spike Receptor Binding Domain heterologous expression
2021· 5 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Gennaro Ciliberto(27), Luigi Aurisicchio(24), Emanuele Marra(18), Rita Mancini(15), Carlo Toniatti(11), Alessia Noto(10), Claudia De Vitis(10), Emiliano Pavoni(9), Stefania Lamartina(8), Laura Luberto(7), Fabiana Fosca Ferrara(7), Arianna Di Napoli(6), Maria Rosaria Giovagnoli(6), Ferdinando Maria Milazzo(6), Fabio Palombo(5), Alberto Rícci(5), Alessia Muzi(5), Giuseppe Giannini(5), Antonella Conforti(5), Mirco Compagnone(5)